NEW YORK, Jan. 20 (GenomeWeb News) - Agilent will launch its Comparative Genomic Hybridization microarray product on Jan. 31, according to an e-mail sent by the company to publicize a related press briefing.
The product, which examines chromosomal changes related to cancer, will be introduced in conjunction with the LabAutomation conference in
Chris van Ingen, head of Agilent's Life Sciences and Chemical Analysis business unit, said at the company's annual analyst meeting in New York in December that the application of microarray-based CGH and location analysis will drive short-term growth for the life science segment of the LSCA unit. This group sells genomics and proteomics tools, including CGH- and location-analysis microarray products, as well as pharmaceutical analysis tools. Van Ingen's comments were reported in the Dec. 16 issue of GenomeWeb News' sister publication, BioCommerce Week.
"The microarray market for gene-expression profiling and genotyping is still fluctuating in growth but the new applications will fuel growth in gene expression higher than 8 to 12 percent," said van Ingen. "It's still a small portion of our business."
The company also plans to introduce a microarray wash station in "early summer," according to the e-mail.